Skip to content

The use of Foscavir for ganciclovir-resistant Cytomegaro virus infection

The use of Foscavir for ganciclovir-resistant Cytomegaro virus infection - The use of Foscavir for CMV

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000024078
Enrollment
1
Registered
2016-10-01
Start date
2016-10-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gancivlovir-resistant CMV infection

Interventions

None listed

Sponsors

Department of dermatology Kumamoto University medical school
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: ganciclovir-resistant CMV infection

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

MeasureTime frame
Improvement of the cytomegalovirus antigenemia test

Countries

Japan

Contacts

Public ContactEiko Nagamoto

Kumamoto University medical school Department of Dermatology

gogohautouto@yahoo.co.jp0963442111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026